Two students have been awarded INPhINIT grants by “la Caixa” Foundation to complete their PhDs on the Can Ruti Campus. Emma Koehorst, has been working on Myotonic Dystrophy in the Neuromuscular and Neuropaediatric research group led by Gisela Nogales at the IGTP since last September. Ifeanyi Ezeonwumelu has started working at the IrsiCaixa on novel therapeutic strategies for HIV with Dr Ester Ballana Guix in the HIV Pathogenesis Group, led by Dr José A Esté.
At the IGTP TODAY
This July the Government of Catalonia officially approved the Plan for Prevention and Control of Hepatitis in Catalonia, which aims to facilitate the adoption and implementation of measures to reduce the number of cases and the morbidity and mortality associated with this infection. This is in line with the goal of the WHO, which aims to eliminate hepatitis C by 2030. The plan is the result of healthcare and public health professionals, experts, representatives of scientific societies and organizations and patients and families associations all working together.
The Director of the Germans Trias I Pujol Research Institute (IGTP), Manel Puig and the Director of the Instituto de Salud Carlos III, Raquel Yotti have put their formal seal on the starting up of the Comparative Medicine and Bioimage Centre of Catalonia (CMCiB). The CMCiB is a centre built on the Can Ruti Campus by the IGTP with the aim of being a reference centre for comparative medicine, bioimaging and computational models and a pioneer in applying alternative methods for biomedical research that impacts on the health of the population. The facilities of the centre include latest generation operating theatres that are adaptable for continued training, perfecting new surgical techniques and development of new surgical devices.
In a brand new format, scientists come together to share and discuss research on the Can Ruti Campus in the First IGTP PI Retreat
Principal investigators from the nine areas of research on the Can Ruti Campus met together to discuss topics of concern in the current research environment. During the day, researchers enjoyed inputs from the IGTP research community and external speakers and were able to take advantage of the many moments available for networking and sharing.
The IGTP Biobank renews its European certification from the Biorepository Proficiency Testing Program
This is the third round of evaluations the IGTP-HGTP Biobank has undertaken to ensure and certify the quality of its services. The Biorepository Proficiency Testing Program is a voluntary external evaluation programme, with members from several countries. Once again, the IGTP-HTP Biobank has been awarded the certificate, opting to apply every two years.
Manremyc, a spin-off of the IGTP specialised in the development of a probiotic against tuberculosis, has opened a funding round through Capital Cell, the first on-line investment platform in Europe specialized in biomedicine. The objective of the campaign is to reach 250,000 euros, with a minimum investment requirement per person of only 600 euros. Up to now, the company has secured 35% of the investment, which includes participation from the Reig family, main shareholders in the pharmaceutical company Reig Jofre.
The Program for Predictive and Personalized Medicine of Cancer (PMPPC) was an initiative of Manuel Perucho and Manel Puig and resulted from the reorganization of the Can Ruti Campus research structure promoted by the Catalan Government in 2014. Dr. Perucho directed the program until March 2019.
Mireia Belmonte the Olympic swimming medallist from Badalona visited the Germans Trias i Pujol Research Institute (IGTP) on Campus Can Ruti on Wednesday 29 May. The event marked the start of a collaboration in support of the Amics de Can Ruti (Friends of Can Ruti) to raise awareness of the importance of health research. During her visit, she presented a watch, which she helped to design, that will soon be available through the web and events organized by the Amics de Can Ruti. All proceeds from the sales of the watch will go to research projects on the campus.
Institutions on the campus held a celebratory workshop; hearing scientific presentations, outlining of work to be done and the signing of a declaration of intentions by the directors. The event closed with a participatory round table session.
How do they do it? How do they get genetic information from a blood sample? How do you manage the genetic information of 20,000 people? How do you get to understand all this information so it can be used for research? These are some of the questions asked by GCAT participants while visiting the National Centre for Genomics Analysis- Centre for Genomic Regulation (CNAG-CRG) and Barcelona Supercomputing Centre (BSC), both centres are collaborating with the project. These questions now have answers.